The polymorphisms of T cell-specific TBX21 and STAT4 genes may contribute to the susceptibility of Chinese individuals to aplastic anemia

Human Immunology

Volumn 73, Issue 1, 2012, Pages 118-121

  Ge, Meili ^a   Zheng, Yizhou ^a   Li, Xingxin ^a   Shi, Jun ^a   Ge, Jing ^a   Li, Huiyuan ^a   Feng, Sizhou ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Aplastic anemia; Polymorphism; STAT4; TBX21

Indexed keywords

STAT4 PROTEIN; TRANSCRIPTION FACTOR T BET;

ADULT; AGED; ALLELE; APLASTIC ANEMIA; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOPLASIA; MAJOR CLINICAL STUDY; MALE; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; ANEMIA, APLASTIC; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STAT4 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84355161385     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.11.007     Document Type: Article

References (28)

1. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
2. You Y., Zhao W., Chen S., Tan W., Dan Y., Hao F., et al. Association of TBX21 gene haplotypes in a Chinese population with systemic lupus erythematosus. Scand J Rheumatol 2010, 39:254-258.
3. Gourh P., Agarwal S.K., Divecha D., Assassi S., Paz G., Arora-Singh R.K., et al. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum 2009, 60:3794-3806.
4. Chae S.C., Shim S.C., Chung H.T. Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis. Exp Mol Med 2009, 41:33-41.
5. Chen S., Zhao W., Tan W., Luo X., Dan Y., You Z., et al. Association of TBX21 promoter polymorphisms with type 1 autoimmune hepatitis in a Chinese population. Hum Immunol 2011, 72:69-73.
6. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
7. Nishikomori R., Usui T., Wu C.Y., Morinobu A., O'Shea J.J., Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002, 169:4388-4398.
8. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
9. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum 2008, 58:1940-1946.
10. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
11. Taylor K.E., Remmers E.F., Lee A.T., Ortmann W.A., Plenge R.M., Tian C., et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008, 4;:e1000084.
12. Martínez A., Varadé J., Márquez A., Cénit M.C., Espino L., Perdigones N., et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008, 58:2598-2602.
13. Zervou M.I., Mamoulakis D., Panierakis C., Boumpas D.T., Goulielmos G.N. STAT4: a risk factor for type 1 diabetes?. Hum Immunol 2008, 69:647-650.
14. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun 2008, 9:267-270.
15. Hu K., Yang P., Jiang Z., Hou S., Du L., Li F. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet's disease. Hum Immunol 2010, 71:723-726.
16. Yang C., Zhang X. Incidence survey of aplastic anemia in China. Chin Med Sci J 1991, 6:203-207.
17. de Latour R.P., Visconte V., Takaku T., Wu C., Erie A.J., Sarcon A.K., et al. Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood 2010, 116:4175-4184.
18. Tsuda H., Yamasaki H. Type I and type II T-cell profiles in aplastic anemia and refractory anemia. Am J Hematol 2000, 64:271-274.
19. Solomou E.E., Keyvanfar K., Young N.S. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 2006, 107:3983-3991.
20. Nakao S., Yamaguchi M., Shiobara S., Yokoi T., Miyawaki T., Taniguchi T., et al. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 1992, 79:2532-2535.
21. Nisticò A., Young N.S. Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994, 120:463-469.
22. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002, 295:338-342.
23. Matsuda J.L., George T.C., Hagman J., Gapin L. Temporal dissection of T-bet functions. J Immunol 2007, 178:3457-3465.
24. Suttner K., Rosenstiel P., Depner M., Schedel M., Pinto L.A., Ruether A., et al. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol 2009, 123:1062-1068. 8 e1-8.
25. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 2007, 119:1218-1224.
26. Chi W., Zhu X., Yang P., Liu X., Lin X., Zhou H., et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008, 49:3058-3064.
27. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
28. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007, 13:711-718.